Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurocrine Biosciences (NBIX) Other Non-Current Assets: 2010-2021

Historic Other Non-Current Assets for Neurocrine Biosciences (NBIX) over the last 11 years, with Sep 2021 value amounting to $3.2 million.

  • Neurocrine Biosciences' Other Non-Current Assets fell 99.25% to $3.2 million in Q3 2021 from the same period last year, while for Sep 2021 it was $3.2 million, marking a year-over-year decrease of 99.25%. This contributed to the annual value of $6.4 million for FY2020, which is 94.46% down from last year.
  • Per Neurocrine Biosciences' latest filing, its Other Non-Current Assets stood at $3.2 million for Q3 2021, which was down 0.00% from $3.2 million recorded in Q2 2021.
  • Neurocrine Biosciences' 5-year Other Non-Current Assets high stood at $428.5 million for Q3 2020, and its period low was $3.2 million during Q2 2021.
  • Its 3-year average for Other Non-Current Assets is $139.7 million, with a median of $6.4 million in 2020.
  • In the last 5 years, Neurocrine Biosciences' Other Non-Current Assets spiked by 9,005.40% in 2020 and then plummeted by 99.25% in 2021.
  • Over the past 5 years, Neurocrine Biosciences' Other Non-Current Assets (Quarterly) stood at $4.5 million in 2017, then grew by 21.71% to $5.5 million in 2018, then surged by 2,008.82% to $115.5 million in 2019, then crashed by 94.46% to $6.4 million in 2020, then slumped by 99.25% to $3.2 million in 2021.
  • Its last three reported values are $3.2 million in Q3 2021, $3.2 million for Q2 2021, and $355.8 million during Q1 2021.